Antithrombin III Supplementation Prior to Cardiopulmonary Bypass for Neonates Undergoing Stage 1 Norwood-Type Palliations.
Phase of Trial: Phase I
Latest Information Update: 21 Feb 2014
At a glance
- Drugs Antithrombin III (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 21 Feb 2014 Status changed from recruiting to discontinued according to ClinicalTrials.gov record.
- 02 Jan 2013 Planned End Date changed from 1 Jan 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 19 Jun 2012 Planned end date changed from 1 Jun 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.